ARTICLE
- AARP
(2021)
A small study has found that the experimental drug donanemab may slow cognitive decline in Alzheimer's patients. It joins others that show promise.
Visibility: Public (all visitors)
Related Chunks
Related chunks with this resource
Saved by FoundryBase
Contains: 18 resources
Contains: 18 resources
No comments yet. Be the first to comment!